603127 logo

Joinn Laboratories(China)Co.,Ltd. Stock Price

SHSE:603127 Community·CN¥19.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

603127 Share Price Performance

CN¥28.28
9.44 (50.11%)
CN¥28.28
9.44 (50.11%)
Price CN¥28.28

603127 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with moderate growth potential.

3 Risks
2 Rewards

Joinn Laboratories(China)Co.,Ltd. Key Details

CN¥1.7b

Revenue

CN¥1.3b

Cost of Revenue

CN¥366.2m

Gross Profit

CN¥141.1m

Other Expenses

CN¥225.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.31
21.95%
13.49%
0%
View Full Analysis

About 603127

Founded
1995
Employees
2551
CEO
Dapeng Gao
WebsiteView website
www.joinnlabs.com

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provides clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.

Recent 603127 News & Updates

Recent updates

No updates